Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Rigel Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 138 | 118 | −20 |
| Shares | 127.9M | 108.7M | −19.2M (−15.0%) |
| Value | $150.3M | $163.1M | +$12.8M (+8.5%) |
New holders (13)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 572,791 | $859.2K | 0.00% |
| Gsa Capital Partners LLP | 95,269 | $143.0K | 0.02% |
| Alpine Global Management, LLC | 35,840 | $54.0K | 0.02% |
| UBS Group AG | 23,037 | $34.6K | 0.00% |
| State of Wyoming | 22,160 | $33.2K | 0.01% |
| Engineers Gate Manager LP | 10,162 | $15.2K | 0.00% |
| Integrated Wealth Concepts LLC | 10,000 | $15.0K | 0.00% |
| Point72 Middle East FZE | 7,169 | $10.8K | 0.00% |
| Advisory Services Network, LLC | 2,000 | $3.00K | 0.00% |
| EWG Elevate Inc. | 500 | $750 | 0.00% |
| Column Capital Advisors, LLC | 310 | $465 | 0.00% |
| GWM Advisors LLC | 1,000 | $2 | 0.00% |
| Nisa Investment Advisors, LLC | 163 | $0 | 0.00% |
Sold out (33)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.